See more : Ehydrogen Solutions, Inc. (EHYD) Income Statement Analysis – Financial Results
Complete financial analysis of NewCardio, Inc. (NWCI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NewCardio, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- EPACK Durable Limited (EPACK.NS) Income Statement Analysis – Financial Results
- Electricité de France S.A. (ECIFF) Income Statement Analysis – Financial Results
- Materials Analysis Technology Inc. (3587.TWO) Income Statement Analysis – Financial Results
- DeepMarkit Corp. (MKTDF) Income Statement Analysis – Financial Results
- Allmed Solutions Ltd (ALMD.TA) Income Statement Analysis – Financial Results
NewCardio, Inc. (NWCI)
Industry: Medical - Devices
Sector: Healthcare
About NewCardio, Inc.
NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development. The company's technology platform provides real-time and 3-D analysis of the heart's electrical activity as detected at the body surface by standard 12-lead electrocardiogram (ECG) electrodes. Its developing products include QTinno, an automated cardiac safety solution that replaces the manual and/or semi-automated methodologies with algorithms that automatically measure, analyze, and report on the ECGs collected; and CardioBip, a mobile ECG transtelephonic system comprising a mobile ECG recording and transmitting device, and a Web enabled software which receives, processes, and analyzes the data. The company is also developing my3KG, a software application to provide a method to assess cardiac electrical activity in time and space. NewCardio, Inc. was founded in 2004 and is based in Branchburg, New Jersey.
Metric | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
---|---|---|---|---|---|---|
Revenue | 257.40K | 0.00 | 0.00 | 0.00 | 0.00 | 1.01M |
Cost of Revenue | 152.30K | 0.00 | 0.00 | 0.00 | 0.00 | 721.93K |
Gross Profit | 105.10K | 0.00 | 0.00 | 0.00 | 0.00 | 292.88K |
Gross Profit Ratio | 40.83% | 0.00% | 0.00% | 0.00% | 0.00% | 28.86% |
Research & Development | 3.59M | 3.05M | 2.13M | 369.67K | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 5.92M | 6.90M | 7.18M | 1.73M | 10.00K | 254.59K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 9.56M | 10.01M | 9.32M | 2.10M | 10.00K | 254.59K |
Cost & Expenses | 9.72M | 10.01M | 9.32M | 2.10M | 10.00K | 976.52K |
Interest Income | 119.18K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 330.66K | 0.00 | 0.00 | 7.20M | 0.00 | 0.00 |
Depreciation & Amortization | 79.91K | 438.82K | 18.61K | 5.65K | 3.94K | 1.96K |
EBITDA | -9.38M | -9.02M | -4.29M | -2.09M | -375.55K | 40.25K |
EBITDA Ratio | -2,934.66% | 0.00% | 0.00% | 0.00% | 0.00% | 3.97% |
Operating Income | -9.46M | -10.01M | -9.32M | -2.10M | -10.00K | 38.29K |
Operating Income Ratio | -3,674.93% | 0.00% | 0.00% | 0.00% | 0.00% | 3.77% |
Total Other Income/Expenses | -2.04M | 421.74K | -4.86M | -7.20M | -368.18K | 0.00 |
Income Before Tax | -11.28M | -9.59M | -14.18M | -9.30M | -10.00K | 0.00 |
Income Before Tax Ratio | -4,384.16% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 2.04M | -421.74K | 4.86M | 0.00 | 7.88K | 0.00 |
Net Income | -11.50M | -9.59M | -14.18M | -9.30M | -17.88K | 38.29K |
Net Income Ratio | -4,466.32% | 0.00% | 0.00% | 0.00% | 0.00% | 3.77% |
EPS | -0.40 | -0.40 | -0.68 | -0.85 | 0.00 | 0.00 |
EPS Diluted | -0.40 | -0.40 | -0.68 | -0.63 | 0.00 | 0.00 |
Weighted Avg Shares Out | 28.64M | 23.73M | 20.95M | 10.95M | 3.98M | 10.25M |
Weighted Avg Shares Out (Dil) | 28.64M | 23.73M | 20.95M | 14.86M | 8.43M | 10.25M |
Source: https://incomestatements.info
Category: Stock Reports